Ginkgo Biloba for Vertigo and Anxiety
Ginkgo biloba (EGb 761) at 240 mg daily is an effective and well-tolerated treatment option for vertigo, particularly in older adults with age-related or chronic vestibular symptoms, and shows efficacy for anxiety disorders at 480 mg daily, though you must discontinue it 2 weeks before any surgical procedures due to bleeding risk.
Perioperative Safety Considerations (Critical)
Before discussing efficacy, the most important clinical caveat: Hold Ginkgo biloba 2 weeks before surgery 1. Ginkgolide B displaces platelet-activating factor from binding sites, decreasing coagulation and potentially interacting with warfarin. While case reports document bleeding events, this remains the standard perioperative recommendation from consensus guidelines 1.
For Vertigo Treatment
Primary Evidence for Efficacy
Ginkgo biloba demonstrates clear benefit for vertigo across multiple contexts:
In age-related vertigo: A 2021 randomized controlled trial showed EGb 761 (80 mg twice daily for 12 weeks) combined with balance training produced clinically relevant improvements, with Dizziness Handicap Inventory scores decreasing from 44.1 to 31.1 2. The treatment showed good pharmacological safety with no reported safety issues.
Compared to standard therapy: A 2014 head-to-head trial found EGb 761 (240 mg daily) equally effective as betahistine (32 mg daily) for vertigo treatment over 12 weeks, with 79% of patients rated "very much improved" or "much improved" versus 70% with betahistine 3. Importantly, EGb 761 demonstrated superior tolerability with fewer adverse events (27 events in 19 patients vs 39 events in 31 patients) 3.
In cerebral arteriosclerosis-related dizziness: A 2022 multi-center trial (404 patients) showed 92.67% effectiveness rate versus 83.07% for control treatment, with no difference in adverse reactions 4.
Mechanism and Duration
The benefit appears mediated through enhanced vestibular compensation 5. Expect treatment duration of 12 weeks minimum for optimal effect, with improvements typically beginning around 4-6 weeks 2, 3.
Dosing for Vertigo
240 mg daily (120 mg twice daily) is the standard effective dose 3, 4.
For Anxiety Treatment
A 2007 randomized, double-blind trial in 107 patients with generalized anxiety disorder (GAD) or adjustment disorder with anxious mood demonstrated:
- High-dose EGb 761 (480 mg daily) significantly reduced Hamilton Anxiety Scale scores by -14.3 points versus -7.8 with placebo (p=0.0003) 6
- Low-dose (240 mg daily) also showed benefit (-12.1 points, p=0.01) with clear dose-response relationship (p=0.003) 6
- Treatment was safe, well-tolerated, and particularly valuable in elderly patients with anxiety related to cognitive decline 6
Dosing for Anxiety
480 mg daily for 4 weeks minimum, though 240 mg daily shows some benefit 6.
Safety Profile
Ginkgo biloba is generally well-tolerated with:
- Low risk of gastrointestinal upset, headache, or allergic reactions (no significant difference from placebo) 7
- No increased risk of bleeding or seizures in clinical trials, despite theoretical concerns 7
- Better tolerability profile than betahistine for vertigo 3
Clinical Pitfalls to Avoid
Don't use for tinnitus: A 2022 Cochrane review found Ginkgo biloba has little to no effect on tinnitus severity (very low-certainty evidence), despite older claims 7. The exception is elderly patients with dementia and comorbid tinnitus, where indirect benefits through anxiety/depression improvement may occur 8.
Warfarin interaction: Monitor INR closely if patient is on warfarin 1.
Insufficient dosing: Using doses below 240 mg daily for vertigo or below 480 mg daily for anxiety may produce suboptimal results 6, 3.
Premature discontinuation: Benefits require 4-12 weeks; don't abandon treatment after 2 weeks 2, 3.